Total Exposure of a Hydroxyapatite Orbital Implant, Five Years after Evisceration: Case Report and Review of the Literature

Lucrèce Joanelle Vydalie Eriga *

Department of Ophthalmology, Hôpital Militaire d’Instruction Mohammed V-Rabat, Morocco.

Fadhloullahi Khidrou Sambou Oumarou

Department of Ophthalmology, Hôpital Militaire d’Instruction Mohammed V-Rabat, Morocco.

Arnaud Hugues Yempabou Yonli

Department of Ophthalmology, Hôpital Militaire d’Instruction Mohammed V-Rabat, Morocco.

Ricardo Mendes

Department of Ophthalmology, Hôpital Militaire d’Instruction Mohammed V-Rabat, Morocco.

Djibril Adédoyin Yaya-Oye

Department of Ophthalmology, Hôpital Militaire d’Instruction Mohammed V-Rabat, Morocco.

Adil EL Khoyali

Department of Ophthalmology, Hôpital Militaire d’Instruction Mohammed V-Rabat, Morocco.

Boui Hatim

Department of Ophthalmology, Hôpital Militaire d’Instruction Mohammed V-Rabat, Morocco.

Yassine Mouzari

Department of Ophthalmology, Hôpital Militaire d’Instruction Mohammed V-Rabat, Morocco.

Abdelbarre Oubaaz

Department of Ophthalmology, Hôpital Militaire d’Instruction Mohammed V-Rabat, Morocco.

*Author to whom correspondence should be addressed.


Abstract

Objective: To describe a case of implant complication after evisceration.

Results: The patient was 28 years old with ocular trauma history and evisceration of the left eye five years previously, and placement of an intraocular ball who consulted to the emergency department with left retro-orbital pain and progressive worsening for one month, associated with abundant purulent oozing secretions. The examination of the left orbital cavity revealed palpebral edema, externalization of the deteriorated hydroxyapatite ball, absence of sclera and conjunctiva, and abundant purulent yellowish secretions. The patient underwent emergency lavage. Antibiotic therapy and revision surgery were performed. The evolution was favorable.

Keywords: Evisceration, beads, antibiotherapy, implant, ball


How to Cite

Eriga , Lucrèce Joanelle Vydalie, Fadhloullahi Khidrou Sambou Oumarou, Arnaud Hugues Yempabou Yonli, Ricardo Mendes, Djibril Adédoyin Yaya-Oye, Adil EL Khoyali, Boui Hatim, Yassine Mouzari, and Abdelbarre Oubaaz. 2024. “Total Exposure of a Hydroxyapatite Orbital Implant, Five Years After Evisceration: Case Report and Review of the Literature”. Asian Journal of Research and Reports in Ophthalmology 7 (1):26-31. https://journalajrrop.com/index.php/AJRROP/article/view/91.

Downloads

Download data is not yet available.

References

Delmas J, Leclerc O, Barreau G, Maitrias P, Adenis JP, Robert PY. Enucleation, evisceration. EMC- Ophthalmology. 2016; 13(3):1-15; 21-660-A-10.

Yoon JS, Lew H, Kim SJ, Lee SY. Exposure rate of hydroxyapatite orbital implants. Ophthalmology. Mars. 2008; 115(3):566-572.e2.

Mourits DL, Moll AC, Bosscha MI, Tan HS, Hartong DT. Orbital implants in retinoblastoma patients: 23 years of experience and a review of the literature. Acta Ophthalmol. Mars. 2016;94(2):165‑7 4.

Morel X et al. Modified evisceration for biocolonizable orbital implant: The four squares technique; J Fr. Ophtalmol. 2004; 27(8):903-906.

Delmas J, et al. Interest of Müller muscle flaps in the surgical treatment of ball exposures of anophthalmic cavities; J fr Ophthalmol. 2014;37:618-622.

MULES PH. Evisceration of the globe, with artificial vitreous, Trans. Ophthalmol. Soc. UK. 1885;5:200-206

Nunery WR, Heinz GW, Bonnin JM, et al. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: Histopathologic correlation and comparison with silicone sphere implants. Ophthalmic Plast. Reconstr. Surg. 1993;9(2):96-104.

Morax S. Use of Gore-Tex (polytetra fluoroethylene) in the anophthalmic socket", Bosniak SL (Ed.), Advances in ophthalmic plastic and reconstructive surgery, Pergamon Press, New-York. 1990;82-87.

Bernache-Assolant D. "Bioceramics: development and properties", The ceramic and glass industry. 1993;883:421-436.

Berges O. Moret J. Imaging of the eye and orbit: radiology, ultrasound, scanner, magnetic resonance imaging, angiography, Encycl. Med. Chir. Paris, Ophthalmology. 1994;21-050-A-10.

Shields CL, Shields JA, Eagle RC, DE Potter P. Histology evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite implant. Am. J. Ophthalmol. 1991;111 :363-366.

Nunery WR, Heinz GW, Bonnin JM, et al. "Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants", Ophthalmic Plast. Reconstr. Surg. 1993;9(2):96- 104.

El-Shahed Fak Sherif MM, Ahmed AT. Management of tissue breakdown and exposure associated with orbital hydroxyapatite implants. Ophthal Plast Reconstruction Surg. 1995;11:91—4

Lin CW, Liao SL. Long-term complications of different porous orbital implants: A 21-year review. Br J Ophthalmol. Mai. 2017;101(5):681‑5.

Zhao Y, Zhang MN, Gao YX, Gao XW, Ren B. Comparative study of modified and conventional secondary hydroxyapatite orbital implantations. Int J Ophthalmol. 2013;6(5):646‑9.

Wu AY, Vagefi MR, Georgescu D, Burroughs JR, Anderson RL. Enduragen Patch Grafts for Exposed Orbital Implants. Orbit. Mars. 2011;30(2):92‑5.

Wang JK, Liao SL, Lai PC, Lin LLK. Prevention of exposure of porous orbital implants following enucleation. Am J Ophthalmol. Janv. 2007;143(1):61‑7.

Aggarwal H, Kumar P, Singh RD, Chand P, Alvi HA. Ocular rehabilitation following socket reconstruction with amniotic membrane transplantation with failed primary hydroxyapatite implant post enucleation. Contact Lens and Anterior Eye. Févr. 2015;38(1):64‑9.